Literature DB >> 2915022

Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection.

R C Welliver1, M Sun, S W Hildreth, R Arumugham, P L Ogra.   

Abstract

We studied the antibody response to the fusion (F) and attachment (G) proteins of respiratory syncytial virus and to purified intact virus in the respiratory secretions of 29 infants and children. The goal of the study was to determine whether the immune response to either of the glycoproteins occurred predominantly in the immunoglobulin A (IgA) as opposed to the IgE isotype, which would indicate that one protein subunit would be a better candidate as a potential vaccine. Antibody responses were determined by using an enzyme-linked immunosorbent assay with purified F and G proteins and sucrose gradient-purified intact virus as targets. Infants and children were capable of developing an antibody response in both the IgA and IgE isotypes to each target antigen. The magnitude of the antibody response to the F protein was essentially similar to that to the intact virus, while responses to the G protein were diminished in infants. A slightly more favorable ratio of IgA to IgE responses was observed against the F protein in comparison to the G protein. While neither protein subunit had the ideal characteristics of inducing an IgA response in the absence of an IgE response, the F protein seems to be a better candidate for use as a vaccine, on the basis of better IgA/IgE ratios.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915022      PMCID: PMC267295          DOI: 10.1128/jcm.27.2.295-299.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Two distinct subtypes of human respiratory syncytial virus.

Authors:  M A Mufson; C Orvell; B Rafnar; E Norrby
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

2.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

Authors:  L J Anderson; J C Hierholzer; C Tsou; R M Hendry; B F Fernie; Y Stone; K McIntosh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

3.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

4.  Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus.

Authors:  R M Hendry; J C Burns; E E Walsh; B S Graham; P F Wright; V G Hemming; W J Rodriguez; H W Kim; G A Prince; K McIntosh
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

5.  Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus.

Authors:  E E Walsh; J J Schlesinger; M W Brandriss
Journal:  J Gen Virol       Date:  1984-04       Impact factor: 3.891

6.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.

Authors:  R C Welliver; D T Wong; M Sun; E Middleton; R S Vaughan; P L Ogra
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

7.  Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.

Authors:  K A Ward; P R Lambden; M M Ogilvie; P J Watt
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

8.  Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence.

Authors:  A Kaul; R Scott; M Gallagher; M Scott; J Clement; P L Ogra
Journal:  Am J Dis Child       Date:  1978-11

9.  Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.

Authors:  B R Murphy; B S Graham; G A Prince; E E Walsh; R M Chanock; D T Karzon; P F Wright
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

10.  Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.

Authors:  B R Murphy; G A Prince; E E Walsh; H W Kim; R H Parrott; V G Hemming; W J Rodriguez; R M Chanock
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

View more
  12 in total

1.  Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

Authors:  K Bendelja; A Gagro; A Bace; R Lokar-Kolbas; V Krsulovic-Hresic; V Drazenovic; G Mlinaric-Galinovic; S Rabatic
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 3.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 4.  Immunopathological mechanisms in respiratory syncytial virus disease.

Authors:  P J Openshaw
Journal:  Springer Semin Immunopathol       Date:  1995

5.  Undetectable IgE responses after respiratory syncytial virus infection.

Authors:  G L Toms; R Quinn; J W Robinson
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

6.  Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections.

Authors:  J C Russi; A Delfraro; M D Borthagaray; B Velazquez; B García-Barreno; M Hortal
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

7.  Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis.

Authors:  M L Everard; G Fox; A F Walls; D Quint; R Fifield; C Walters; A Swarbrick; A D Milner
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

8.  Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.

Authors:  D D Erdman; L J Anderson
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 9.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

10.  Cellular and humoral immunity of virus-induced asthma.

Authors:  Yoshimichi Okayama
Journal:  Front Microbiol       Date:  2013-08-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.